COMMUNIQUÉS West-GlobeNewswire

BioPorto to redraw U.S. application for regulatory clearance of The NGAL Test™ for risk assessment for AKI in patients under the age of 22 with the intend to resubmit in Q4 2019
13/07/2019
July 13, 2019 Announcement no. 14 BioPorto to redraw U.S. application for regulatory clearance of The NGAL Test™ for risk assessment for AKI in patients under the age of 22 with the intend to resubmit in Q4 2019 [...]
Aras Azadian, Setu Purohit and Kyle Langstaff Announce Positions in Avicanna Inc.
13/07/2019
TORONTO, July 12, 2019 (GLOBE NEWSWIRE) -- This news release is being disseminated as required by National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in connection [...]
Helius Medical Technologies, Inc. Announces Results of Matters Submitted for Vote at 2019 Annual Meeting of Stockholders
12/07/2019
NEWTOWN, Pa., July 12, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, announced today the results of [...]
HealthEquity Announces Closing of Follow-On Offering and Over-Allotment Option
12/07/2019
DRAPER, Utah, July 12, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest independent health savings account non-bank custodian, today announced the closing of the underwritten public [...]
Eton Pharmaceuticals Provides Update on EM-100 Program
12/07/2019
DEER PARK, Ill., July 12, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that [...]
Extendicare Announces Timing of 2019 Second Quarter Results and Conference Call
12/07/2019
MARKHAM, Ontario, July 12, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the second quarter of 2019, after [...]
RECORDATI TO ACQUIRE WORLDWIDE RIGHTS TO SIGNIFOR® AND OSILODROSTAT (LCI699)
12/07/2019
RECORDATI TO ACQUIRE WORLDWIDE RIGHTS TO SIGNIFOR® AND OSILODROSTAT (LCI699) Milan, 12 July 2019 – Recordati announces the signing of an agreement with Novartis for the acquisition of worldwide rights to Signifor® and [...]
Spineway : Notice of the Ordinary and Extraordinary General Shareholders’ Meeting to be held 24 July 2019
12/07/2019
Notice of the Ordinary and Extraordinary General Shareholders’ Meeting to be held 24 July 2019 Arrangements for availability of preparatory documents Spineway’s General Shareholders’ Meeting called for 2 p.m. on 28 June [...]
SPINEWAY : Convocation à l'Assemblée Générale Mixte du 24 juillet 2019
12/07/2019
Convocation à l'Assemblée Générale Mixte du 24 juillet 2019 Modalités de mise à disposition des documents préparatoires L'Assemblée Générale des actionnaires de Spineway, convoquée le 28 juin 2019 à 14 heures au siège [...]
DLT Resolution Inc. Delayed Financial Reporting F18 10K and Q1 2019 Update
12/07/2019
Las Vegas, NV, July 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- DLT Resolution Inc. (OTC: DLTI), a Distributed Ledger Technology (“Blockchain”) Data Management, Information Technology and Telecommunications company [...]
Genmab Announces Submission of Biologics License Application to U.S. FDA for Subcutaneous Formulation of Daratumumab
12/07/2019
Company Announcement BLA submitted to U.S. FDA for subcutaneous formulation of daratumumab Submission based on data from Phase III COLUMBA and Phase II PLEIADES studies Copenhagen, Denmark; July 12, 2019 – Genmab A/S ( [...]
Overturning ObamaCare Would Benefit Americans, Association of American Physicians and Surgeons (AAPS) Tells President and Congress
12/07/2019
Tucson, Ariz., July 12, 2019 (GLOBE NEWSWIRE) -- After the July 9 oral argument in Texas v. Azar , supporters of the Affordable Care Act (ACA or ObamaCare) worried that the Fifth Circuit Court of Appeals might rule the [...]
Todos Medical to Appoint Dr. Paula Trzepacz As Chief Medical Officer And Files New Patent Application
12/07/2019
Joint venture Breakthrough Diagnostics files new patent application covering Alzheimer’s blood diagnostic LymPro Test clinical correlation with amyloid PET imaging Preliminary Data on LymPro vs. amyloid PET to be [...]
HMS to Report Second Quarter Financial Results on August 2, 2019
12/07/2019
IRVING, Texas, July 12, 2019 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (Nasdaq: HMSY) today announced it will report financial and operating results for the second quarter and six-month period ended June 30, 2019 on Friday [...]
Olainfarm Group sales in the first half of the year increased by 7%
12/07/2019
Preliminary consolidated results for the first six months of 2019 demonstrate an increase by 7%, compared to the six-month period of 2018, reaching 66.3 million euros. Preliminary consolidated results of JSC Olainfarm [...]
NeuBase Therapeutics Closes Merger Transaction with Ohr Pharmaceutical
12/07/2019
Company expects to initiate trading on NASDAQ Under Ticker Symbol “NBSE” effective July 15, 2019 Company completes previously announced financing of approximately $9 million immediately prior to closing of the merger [...]
Progenics Announces Preliminary Voting Results of Annual Meeting of Shareholders
12/07/2019
Commences Search Process to Identify New Board Candidates, Welcomes Input from All Shareholders NEW YORK, July 12, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing [...]
Generex Biotechnology Announces Closing on Acquisition of MediSource Partners
12/07/2019
Medisource Partners is an FDA registered distributor with an extensive portfolio of medical and surgical products including bone grafts and biologics Partnerships and contracts with hospital systems for ordering, [...]
Sonoma Pharmaceuticals Regains Compliance with Nasdaq® Minimum Bid Price Rule
12/07/2019
PETALUMA, Calif., July 12, 2019 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a specialty pharmaceutical company dedicated to identifying, developing and commercializing unique, differentiated [...]

Pages